ORAMED PHARMACEUTICALS INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ORAMED PHARMACEUTICALS INC. stock issued during period, value, issued for services for the quarter ending 2023-12-31 was $0.00.
- ORAMED PHARMACEUTICALS INC. stock issued during period, value, issued for services for the quarter ending 2023-09-30 was $7.00K.
- ORAMED PHARMACEUTICALS INC. stock issued during period, value, issued for services for the quarter ending 2020-08-31 was $0.00, a 100.00% decline year-over-year.
- ORAMED PHARMACEUTICALS INC. stock issued during period, value, issued for services for the quarter ending 2020-05-31 was $8.00K, a 20.00% decline year-over-year.
- ORAMED PHARMACEUTICALS INC. stock issued during period, value, issued for services for fiscal 2023 was $9.00K, a 59.09% decline from fiscal 2022.
- ORAMED PHARMACEUTICALS INC. stock issued during period, value, issued for services for fiscal 2022 was $22.00K.
- ORAMED PHARMACEUTICALS INC. stock issued during period, value, issued for services for fiscal 2020 was $38.00K, a 30.91% decline from fiscal 2019.
- ORAMED PHARMACEUTICALS INC. stock issued during period, value, issued for services for fiscal 2019 was $55.00K, a 44.44% decline from fiscal 2018.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $9.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $7.00K 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $22.00K 10-K · filed 2024-03-06 | |
| 2020-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-24 | $38.00K 10-K · filed 2021-11-24 |
| 2020-05-31 | $8.00K 10-Q · filed 2021-07-14 | $39.00K derived: sum of 4 quarters · filed 2021-07-14 |
| 2020-02-29 | $13.00K 10-Q · filed 2021-04-13 | $41.00K derived: sum of 4 quarters · filed 2021-04-13 |
| 2019-11-30 | $17.00K 10-Q · filed 2021-01-14 | $36.00K derived: sum of 4 quarters · filed 2021-01-14 |
| 2019-08-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-24 | $55.00K 10-K · filed 2020-11-24 |
| 2019-05-31 | $10.00K 10-Q · filed 2020-07-07 | $93.00K derived: sum of 4 quarters · filed 2020-07-07 |
| 2019-02-28 | $8.00K 10-Q · filed 2020-04-06 | $100.00K derived: sum of 4 quarters · filed 2020-04-06 |
| 2018-11-30 | $36.00K 10-Q · filed 2020-01-09 | $111.00K derived: sum of 4 quarters · filed 2020-01-09 |
| 2018-08-31 | $39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | $99.00K 10-K · filed 2019-11-27 |
| 2018-05-31 | $17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-07-10 | $81.00K derived: sum of 4 quarters · filed 2019-11-27 |
| 2018-02-28 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-10 | $83.00K derived: sum of 4 quarters · filed 2019-11-27 |
| 2017-11-30 | $24.00K 10-Q · filed 2019-01-14 | $79.00K derived: sum of 4 quarters · filed 2019-11-27 |
| 2017-08-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | $72.00K 10-K · filed 2019-11-27 |
| 2017-05-31 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-07-06 | $71.00K derived: sum of 4 quarters · filed 2018-11-28 |
| 2017-02-28 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-04-05 | $85.00K derived: sum of 4 quarters · filed 2018-11-28 |
| 2016-11-30 | $17.00K 10-Q · filed 2017-01-11 | $93.00K derived: sum of 4 quarters · filed 2018-11-28 |
| 2016-08-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-28 | $101.00K 10-K · filed 2018-11-28 |
| 2016-05-31 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-07-06 | $105.00K derived: sum of 4 quarters · filed 2017-11-29 |
| 2016-02-29 | $23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-04-06 | $115.00K derived: sum of 4 quarters · filed 2017-11-29 |
| 2015-11-30 | $25.00K 10-Q · filed 2016-01-13 | $92.00K derived: sum of 4 quarters · filed 2017-11-29 |
| 2015-08-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-29 | $93.00K 10-K · filed 2017-11-29 |
| 2015-05-31 | $43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-07-01 | $106.60K derived: sum of 4 quarters · filed 2016-11-25 |
| 2015-02-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-04-03 | $63.60K derived: sum of 4 quarters · filed 2016-11-25 |
| 2014-11-30 | $26.00K 10-Q · filed 2015-01-08 | |
| 2014-08-31 | $37.60K derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-25 | $102.00K 10-K · filed 2016-11-25 |
| 2014-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-14 | |
| 2013-08-31 | $245.00K 10-K · filed 2015-11-25 | |
| 2012-08-31 | $108.00K 10-K · filed 2014-11-14 | |
| 2011-08-31 | $227.57K 10-Q · filed 2014-04-10 | |
| 2010-08-31 | $249.85K 10-Q · filed 2014-04-10 | |
| 2009-08-31 | $152.93K 10-Q · filed 2014-04-10 | |
| 2008-08-31 | $116.11K 10-Q · filed 2014-04-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |